MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Avinger Company Profile (NASDAQ:AVGR)

Consensus Ratings for Avinger (NASDAQ:AVGR) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $19.33 (62.06% upside)

Analysts' Ratings History for Avinger (NASDAQ:AVGR)
Show:
DateFirmActionRatingPrice TargetActions
3/30/2016Canaccord GenuityReiterated RatingBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2016BTIG ResearchLower Price TargetBuy$24.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/4/2016Dougherty & CoDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/15/2015OppenheimerReiterated RatingOutperform$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2015Cowen and CompanyInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2015StephensInitiated CoverageOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for Avinger (NASDAQ:AVGR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/26/2016        
5/4/2016Q1($1.17)($1.28)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/1/2016Q4($1.04)($1.07)$2.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315($0.88)($1.08)$3.10 million$2.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2015Q215($0.90)($0.83)$2.72 million$3.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q1($1.15)($1.53)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2015Q414($0.77)($33.62)$3.10 million$3.07 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Avinger (NASDAQ:AVGR)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($1.17)($1.17)($1.17)
Q2 20161($1.16)($1.16)($1.16)
Q3 20161($1.08)($1.08)($1.08)
Q4 20161($0.95)($0.95)($0.95)
(Data provided by Zacks Investment Research)
Dividend History for Avinger (NASDAQ:AVGR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Avinger (NASDAQ:AVGR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/6/2016Donald A LucasDirectorSell9,309$12.58$117,107.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2016Himanshu PatelInsiderSell10,000$13.40$134,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2016John B Ph D Md SimpsonMajor ShareholderSell75,111$13.11$984,705.21View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2016John B Ph D Md SimpsonMajor ShareholderSell40,000$11.44$457,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2016Matthew FergusonCFOBuy1,500$11.37$17,055.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/14/2015Donald A LucasDirectorSell2,500$16.22$40,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2015Donald A LucasDirectorSell4,000$15.92$63,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2015John B Ph D Md SimpsonMajor ShareholderSell100,000$17.26$1,726,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2015John B Ph D Md SimpsonChairmanSell42,445$17.20$730,054.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015Himanshu PatelCTOSell1,731$13.00$22,503.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015James CullenDirectorSell2,307$13.00$29,991.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015Matthew FergusonCFOSell1,154$13.00$15,002.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Avinger (NASDAQ:AVGR)
DateHeadline
06/27/16 03:21 PMHighmark Health’s VITAL Program to Evaluate Avinger’s Novel Treatment for Peripheral Artery Disease - [at noodls] - PITTSBURGH and REDWOOD CITY, Calif., June 27, 2016 (GLOBE NEWSWIRE) -- Highmark Health, Allegheny Health Network (AHN) and Avinger, Inc. (NASDAQ:AVGR) announced a collaboration today to evaluate Pantheris™, ...
06/27/16 07:23 AMAvinger (AVGR) Looks Good: Stock Adds 5.4% in Session
06/26/16 06:59 AMThese 5 Stocks Are Ready to Break Out Now -
06/17/16 03:02 PMAVINGER INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet -
06/15/16 03:19 PMAvinger, Inc. Announces Drawdown of $10 Million Under Term Loan Facility with CRG - [at noodls] - REDWOOD CITY, Calif., June 15, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a leading developer of innovative treatments for peripheral artery disease (PAD), announced today that it has completed ...
06/15/16 03:05 PM4:05 pm Avinger completes second drawdown from term loan facility w/ CRG for proceeds of $10 million before closing fees -
06/07/16 03:03 PMAVINGER INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/26/16 06:14 PMETF’s with exposure to Avinger, Inc. : May 26, 2016 -
05/26/16 01:51 PMEarnings Review and Stock Rundown for Avinger, Inc. (NASDAQ:AVGR) - Wall Street Hints and News - Earnings Review and Stock Rundown for Avinger, Inc. (NASDAQ:AVGR)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Avinger, Inc. (NASDAQ:AVGR) to post ...and more »
05/16/16 09:45 AMAvinger, Inc. :AVGR-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/09/16 04:00 PMAVINGER INC Files SEC form 10-Q, Quarterly Report -
05/04/16 04:21 PMAvinger reports 1Q loss -
05/04/16 03:31 PMAvinger, Inc. Announces First Quarter 2016 Results - [at noodls] - REDWOOD CITY, Calif., May 04, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported results for the first ...
05/04/16 03:30 PMAvinger Inc Earnings Call scheduled for 4:30 pm ET today -
05/04/16 03:09 PMAVINGER INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements and -
05/04/16 06:07 AMQ1 2016 Avinger Inc Earnings Release - After Market Close -
04/27/16 03:27 PMAvinger, Inc. to Announce First Quarter 2016 Results on Wednesday, May 4, 2016 - [at noodls] - REDWOOD CITY, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it will release ...
04/11/16 11:24 AMEdited Transcript of AVGR earnings conference call or presentation 1-Mar-16 9:30pm GMT -
03/24/16 09:50 AMThese 5 Under-$10 Stocks Are Set to Soar Higher -
03/16/16 09:27 AMAvinger (AVGR): Moving Average Crossover Alert -
02/23/16 03:05 PMAvinger, Inc. to Present Cowen and Company 36th Annual Health Care Conference - [GlobeNewswire] - REDWOOD CITY, Calif., Feb. 23, 2016-- Avinger, Inc., a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial disease and pioneer of the lumivascular ...
02/18/16 07:00 AMAvinger, Inc. to Announce Fourth Quarter and Year-End 2015 Results on Tuesday, March 1, 2016 - [GlobeNewswire] - REDWOOD CITY, Calif., Feb. 18, 2016-- Avinger, Inc., a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial disease and pioneer of the Lumivascular ...
01/04/16 03:20 PMAvinger, Inc. Names Joseph Rafferty as Vice President of Sales - [at noodls] - , (GLOBE NEWSWIRE) -- , (NASDAQ:AVGR) a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial disease (PAD) and pioneer of the lumivascular approach ...
12/29/15 11:50 AMAvinger downgraded by Dougherty & Company -
12/28/15 05:47 PMBest IPOs of 2015 -
12/23/15 03:07 PMAVINGER INC Files SEC form 8-K, Change in Directors or Principal Officers -
12/23/15 08:27 AMAvinger, Inc. Earnings Analysis: Q3, 2015 By the Numbers -
12/08/15 12:17 PMAVINGER INC Financials -
12/01/15 03:36 PMAvinger Announces Filing of 510(k) Application for Enhanced Version of Pantheris(TM) - [at noodls] - REDWOOD CITY, Calif., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial disease ...
About Avinger

Avinger logoAvinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses to introduce products based on its lumivascular platform, which is an intravascular image-guided system. The Company manufactures and sells a suite of products in the United States and select European markets. The Company's products include Lightbox imaging console, as well as Wildcat, Kittycat and the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO). The Company's lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AVGR
  • CUSIP:
Key Metrics:
  • Previous Close: $11.93
  • 50 Day Moving Average: $11.29
  • 200 Day Moving Average: $13.61
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $151.43M
  • Current Quarter EPS Consensus Estimate: $-4.22 EPS
Additional Links:
Avinger (NASDAQ:AVGR) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha